Please login to the form below

Not currently logged in
Email:
Password:

Restructuring

This page shows the latest Restructuring news and features for those working in and with pharma, biotech and healthcare.

Sanofi exits Zynquista alliance with Lexicon

Sanofi exits Zynquista alliance with Lexicon

following an R&D restructuring.

Latest news

  • Boehringer’s head of pharma heads for the exit Boehringer’s head of pharma heads for the exit

    Comes amid restructuring and bolt-on deals to bolster business. German drugmaker Boehringer Ingelheim is making changes at the top following the news that head of pharma Allan Hillgrove is retiring. ... also been particularly active of late in expanding

  • AZ and Novartis ‘most exposed’ to Senate pricing proposals AZ and Novartis ‘most exposed’ to Senate pricing proposals

    In a research note, Jefferies say that among all the elements in the Prescription Drug Pricing Reduction Act (PDPRA) that cleared the Senate Finance Committee last week it is the restructuring

  • Dupixent drives Sanofi again, but other new drugs are lagging Dupixent drives Sanofi again, but other new drugs are lagging

    Reported loss due to restructuring. Sanofi has raised its forecasts for the year after a “solid” second quarter marked by another sales acceleration for immunology drug Dupixent, although it posted a ... loss due to restructuring costs.

  • Sanofi sheds jobs in R&D restructuring Sanofi sheds jobs in R&D restructuring

    466 jobs will be cut, with diabetes and cardiovascular R&D bearing the brunt of the restructuring at the French pharma company. ... Sanofi’s restructuring of its R&D organisation is headed by John Reed, its new R&D chief, who joined from Roche last year

  • Solid Q1 results lift Pfizer as it waits for pipeline boost Solid Q1 results lift Pfizer as it waits for pipeline boost

    It’s not surprising that there were no big revelations from Bourla in the first-quarter report, as he has already started implementing a series of major restructuring initiatives announced as

More from news
Approximately 4 fully matching, plus 290 partially matching documents found.

Latest Intelligence

  • Changing direction: adapting to a rapidly-evolving environment Changing direction: adapting to a rapidly-evolving environment

    Consolidation over the course of the past two decades – through high profile M&A, strategic alliances and widespread restructuring – has redrawn the size and shape of the sector.

  • Relearning launch: Four key dynamics for pharma launches in 2019 Relearning launch: Four key dynamics for pharma launches in 2019

    The NHS is restructuring to give significantly more control to seven regional directors who will be responsible for the complex triple bottom line of quality, finance and operational performance.

  • Nudge-nudge, think-think Nudge-nudge, think-think

    According to the review, programmes that include educational outreach and ‘relational restructuring’ – reinforced by modified peer group norms that reflect the expectations of an external reference group – are most likely to

  • Advancing women in healthcare Advancing women in healthcare

    Centers for Disease Control and Prevention (CDC) and overseeing a restructuring of the government agency’s multibillion dollar budget and 10, 000 employees.

  • Managing misconduct allegations Managing misconduct allegations

    An investigation will necessarily cause disruptions and the company may need to put on hold promotions or restructurings for the duration of the investigation.

More from intelligence
Approximately 0 fully matching, plus 25 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics